Most cited papers in Vascular Anomalies and Treatments
What are the most cited papers in Vascular Anomalies and Treatments?
The most cited paper in Vascular Anomalies and Treatments is "Haemodynamic definitions and updated clinical classification of pulmonary hypertension" (Gérald Simonneau, David Montani, David Stephen Celermajer et al., 2018), with 3,872 citations. Next come "Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension" (2,489) and "ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension" (2,369).
Showing 50 of 100 papers. Every paper with more than 405 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Haemodynamic definitions and updated clinical classification of pulmonary hypertension Gérald Simonneau, David Montani, David Stephen Celermajer et al. · European Respiratory Journal | 13 Dec 2018 | 3,872 |
| 2 | Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension Nazzareno Galiè, Hossein Ardeschir Ghofrani, Adam Torbicki et al. · New England Journal of Medicine | 16 Nov 2005 | 2,489 |
| 3 | ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch et al. · Journal of the American College of Cardiology | Apr 2009 | 2,369 |
| 4 | Updated Clinical Classification of Pulmonary Hypertension Gérald Simonneau, Ivan M. Robbins, Maurice Beghetti et al. · Journal of the American College of Cardiology | Jun 2009 | 2,097 |
| 5 | Clinical classification of pulmonary hypertension Gérald Simonneau, Nazzareno Galiè, Lewis J. Rubin et al. · Journal of the American College of Cardiology | Jun 2004 | 1,906 |
| 6 | Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) Claire L. Shovlin, Alan E. Guttmacher, Elisabetta Buscarini et al. · American Journal of Medical Genetics | 6 Mar 2000 | 1,760 |
| 7 | Cellular and molecular pathobiology of pulmonary arterial hypertension Marc Humbert, Nicholas W. Morrell, Stephen L. Archer et al. · Journal of the American College of Cardiology | Jun 2004 | 1,574 |
| 8 | DISSECTING ANEURYSM OF THE AORTA Albert E. Hirst, Varner J. Johns, S. WESLEY KIME · Medicine | Sep 1958 | 1,547 |
| 9 | Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Kimberly A. McAllister, K.M. Grogg, David Wayne Johnson et al. · Nature Genetics | Dec 1994 | 1,507 |
| 10 | Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè et al. · American Journal of Respiratory and Critical Care Medicine | Mar 2002 | 1,420 |
| 11 | The Pathology of Hypertensive Pulmonary Vascular Disease Donald Heath, Jesse E. Edwards · Circulation | Oct 1958 | 1,257 |
| 12 | Chronic Thromboembolic Pulmonary Hypertension Marius M. Hoeper, Eckhard Mayer, Gérald Simonneau et al. · Circulation | 24 Apr 2006 | 1,158 |
| 13 | Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 David Wayne Johnson, Jonathan N. Berg, Melanie A. Baldwin et al. · Nature Genetics | Jun 1996 | 1,132 |
| 14 | Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis Francis X. McCormack et al. · New England Journal of Medicine | 16 Mar 2011 | 1,131 |
| 15 | Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ Matthew D. Shirley, Hao Tang, Carol J. Gallione et al. · New England Journal of Medicine | 8 May 2013 | 1,116 |
| 16 | International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia Marie E. Faughnan et al. · Journal of Medical Genetics | 23 Jun 2009 | 1,089 |
| 17 | Hereditary Hemorrhagic Telangiectasia Alan E. Guttmacher, Douglas A. Marchuk, Robert I. White · New England Journal of Medicine | 5 Oct 1995 | 1,072 |
| 18 | Vascular disorders of the liver # † Laurie D. DeLeve, Dominique Charles Valla, Guadalupe García–Tsao · Hepatology | 9 Dec 2008 | 970 |
| 19 | Giant-cell Granuloma of the Respiratory Tract (Wegener's Granulomatosis) E. W. Walton · BMJ | 2 Aug 1958 | 942 |
| 20 | Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension Michael D. McGoon, David D. Gutterman, Virginia Steen et al. · CHEST Journal | Jul 2004 | 936 |
| 21 | Molecular pathogenesis of pulmonary arterial hypertension Marlene Rabinovitch · Journal of Clinical Investigation | Jul 2008 | 889 |
| 22 | Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis Suk Paul Oh, Tsugio Seki, Kendrick A. Goss et al. · Proceedings of the National Academy of Sciences | 14 Mar 2000 | 865 |
| 23 | Defective Angiogenesis in Mice Lacking Endoglin Dean Y. Li, Lise K. Sorensen, Benjamin S. Brooke et al. · Science | 28 May 1999 | 861 |
| 24 | A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma Christine Léauté-Labrèze et al. · New England Journal of Medicine | 18 Feb 2015 | 804 |
| 25 | An epidemiological study of pulmonary arterial hypertension Adrian Peacock, Niamh F Murphy, John J.V. McMurray et al. · European Respiratory Journal | 14 Mar 2007 | 797 |
| 26 | Predictors of hemorrhage in patients with untreated brain arteriovenous malformation Christian Stapf, Henning Mast, Robert R. Sciacca et al. · Neurology | 9 May 2006 | 789 |
| 27 | Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis Coen A. Stegeman, Jan Willem Cohen Tervaert, Paul E. de Jong et al. · New England Journal of Medicine | 4 Jul 1996 | 778 |
| 28 | Endothelial Dysfunction in Pulmonary Hypertension Rohit Budhiraja, Rubin M. Tuder, Paul M. Hassoun · Circulation | 20 Jan 2004 | 772 |
| 29 | An Atypical Variant of Fabry's Disease in Men with Left Ventricular Hypertrophy Shoichiro Nakao, Toshihiro Takenaka, Masato Maeda et al. · New England Journal of Medicine | 3 Aug 1995 | 767 |
| 30 | Pulmonary Arteriovenous Malformations: A State of the Art Review James R. Gossage, GHASSAN KANJ · American Journal of Respiratory and Critical Care Medicine | Aug 1998 | 762 |
| 31 | A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4) Carol J. Gallione, Gabriela M. Repetto, Eric Legius et al. · The Lancet | Mar 2004 | 761 |
| 32 | Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era Jamie McDonald, Whitney L. Wooderchak‐Donahue, Chad VanSant Webb et al. · Frontiers in Genetics | 26 Jan 2015 | 747 |
| 33 | Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia Richard C. Trembath, Jennifer R. Thomson, Rajiv D. Machado et al. · New England Journal of Medicine | 2 Aug 2001 | 727 |
| 34 | Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells Laurent David, Christine Mallet, Sabine Mazerbourg et al. · Blood | 26 Oct 2006 | 717 |
| 35 | Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Athénaïs Boucly, Jason C. Weatherald, Laurent Savale et al. · European Respiratory Journal | Aug 2017 | 709 |
| 36 | Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg‐Strauss syndrome Renato Alberto Sinico, Lucafrancesco Di Toma, Umberto Maggiore et al. · Arthritis & Rheumatism | Sep 2005 | 695 |
| 37 | Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma Riad Salem, Andrew C. Gordon, Samdeep K. Mouli et al. · Gastroenterology | 2 Sep 2016 | 693 |
| 38 | Tracheomalacia and Tracheobronchomalacia in Children and Adults Kelly A. Carden, Philip M. Boiselle, David A. Waltz et al. · CHEST Journal | Mar 2005 | 672 |
| 39 | Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma Riad Salem et al. · Gastroenterology | 31 Oct 2010 | 651 |
| 40 | Central Airway Obstruction Armin Ernst, David J Feller-Kopman, Heinrich D. Becker et al. · American Journal of Respiratory and Critical Care Medicine | Jun 2004 | 637 |
| 41 | Pulmonary Vascular Lesions Occurring in Patients With Chronic Major Vessel Thromboembolic Pulmonary Hypertension KENNETH M. MOSER, Colin M. Bioor · CHEST Journal | Mar 1993 | 634 |
| 42 | Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management Erika B. Rosenzweig, Steven H. Abman, Ian Adatia et al. · European Respiratory Journal | 13 Dec 2018 | 630 |
| 43 | Sirolimus for the treatment of complicated vascular anomalies in children Adrienne M. Hammill, MarySue Wentzel, Anita Kumari Gupta et al. · Pediatric Blood & Cancer | 28 Mar 2011 | 629 |
| 44 | TGF-β signaling in vascular biology and dysfunction Marie‐José Goumans, Zhen Liu, Peter ten Dijke · Cell Research | 30 Dec 2008 | 622 |
| 45 | Genetics and Genomics of Pulmonary Arterial Hypertension Florent Soubrier, Wendy K. Chung, Rajiv D. Machado et al. · Journal of the American College of Cardiology | Dec 2013 | 622 |
| 46 | Pulmonary Endarterectomy: Recent Changes in a Single Institution's Experience of More Than 2,700 Patients Michael M. Madani, William R. Auger, Victor Gert Pretorius et al. · The Annals of Thoracic Surgery | 23 May 2012 | 607 |
| 47 | Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Thomas F. Hiemstra, Michael W. Walsh, Alfred Mahr et al. · JAMA | 9 Nov 2010 | 596 |
| 48 | Age‐related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population Henri Plauchu, Jean‐Pierre de Chadarévian, Alain Bideau et al. · American Journal of Medical Genetics | Mar 1989 | 588 |
| 49 | ERS statement on chronic thromboembolic pulmonary hypertension Marion Delcroix et al. · European Respiratory Journal | 17 Dec 2020 | 583 |
| 50 | Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Jonathan Gribbin, Richard Hubbard, Ivan Le Jeune et al. · Thorax | 15 Jul 2006 | 575 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.